메뉴 건너뛰기




Volumn 55, Issue 4, 2009, Pages 225-232

Efficacy of antiretroviral therapy program in children in India: Prognostic factors and survival analysis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; HEMOGLOBIN; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

EID: 70349445090     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmm073     Document Type: Article
Times cited : (19)

References (16)
  • 1
    • 70349469340 scopus 로고    scopus 로고
    • WHO World Health Organisation. http://www.who.int/hiv/mediacentre/ 2006_EpiUpdate_en.pdf. (20 December 2006, date last accessed).
    • WHO World Health Organisation. http://www.who.int/hiv/mediacentre/ 2006_EpiUpdate_en.pdf. (20 December 2006, date last accessed).
  • 3
    • 70349448188 scopus 로고    scopus 로고
    • United Nations Acquired Immune Deficiency Syndrome. Global summary of the HIV/AIDS epidemic. December 2005. http://www.unaids.org/Unaids/EN/ Resources/epidemiology/epicore.asp (28 December 2005, date last accessed).
    • United Nations Acquired Immune Deficiency Syndrome. Global summary of the HIV/AIDS epidemic. December 2005. http://www.unaids.org/Unaids/EN/ Resources/epidemiology/epicore.asp (28 December 2005, date last accessed).
  • 4
    • 8244246438 scopus 로고    scopus 로고
    • Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children
    • Englund JA, Baker CJ, Raskino C, et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. N Engl J Med 1997;336:1704-12.
    • (1997) N Engl J Med , vol.336 , pp. 1704-1712
    • Englund, J.A.1    Baker, C.J.2    Raskino, C.3
  • 5
    • 7344247127 scopus 로고    scopus 로고
    • A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children
    • Paediatric European Network for Treatment of AIDS
    • Paediatric European Network for Treatment of AIDS. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children. AIDS 1998;12:F151-60.
    • (1998) AIDS , vol.12
  • 6
    • 17644442890 scopus 로고    scopus 로고
    • Combination therapy with stavudine (d4T) plus didanosie (ddl) in children with Human Immunodeficiency Virus infection
    • Kline MW, Van Dyke RB, Lindsey JC, et al. Combination therapy with stavudine (d4T) plus didanosie (ddl) in children with Human Immunodeficiency Virus infection. Pediatrics 1999;103:62-9.
    • (1999) Pediatrics , vol.103 , pp. 62-69
    • Kline, M.W.1    Van Dyke, R.B.2    Lindsey, J.C.3
  • 7
    • 0032873156 scopus 로고    scopus 로고
    • Pediatric HIV-1 infection
    • Burns DN, Mofenson LM. Pediatric HIV-1 infection. Lancet 1999;354(Suppl 2): S1-6.
    • (1999) Lancet , vol.354 , Issue.SUPPL. 2
    • Burns, D.N.1    Mofenson, L.M.2
  • 8
    • 34147098059 scopus 로고    scopus 로고
    • Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa
    • Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr, 2007;7:13.
    • (2007) BMC Pediatr , vol.7 , pp. 13
    • Reddi, A.1    Leeper, S.C.2    Grobler, A.C.3
  • 9
    • 70349440626 scopus 로고    scopus 로고
    • World Health Organization (WHO). Scaling up antiretroviral therapy in resource-limited settings. Geneva, 2004. http://www.who.int/hiv/pub/ prev_care/en/arvrevision2003en.pdf (1 December 2006, date last accessed).
    • World Health Organization (WHO). Scaling up antiretroviral therapy in resource-limited settings. Geneva, 2004. http://www.who.int/hiv/pub/ prev_care/en/arvrevision2003en.pdf (1 December 2006, date last accessed).
  • 10
    • 20144377456 scopus 로고    scopus 로고
    • Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001
    • McConnel SM, Byers RH, Frederick T, et al. Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr 2005;38:488-94.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 488-494
    • McConnel, S.M.1    Byers, R.H.2    Frederick, T.3
  • 11
    • 0035936007 scopus 로고    scopus 로고
    • Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1
    • Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345:1522-8.
    • (2001) N Engl J Med , vol.345 , pp. 1522-1528
    • Gortmaker, S.L.1    Hughes, M.2    Cervia, J.3
  • 12
    • 0032731973 scopus 로고    scopus 로고
    • Use of observational databases to evaluate the effectiveness to evaluate the effectiveness of antiretroviral therapy for HIV infection: Comparison of cohort studies with randomized controlled trials
    • Phillips AN, Grabar S, Tassie JM, et al. Use of observational databases to evaluate the effectiveness to evaluate the effectiveness of antiretroviral therapy for HIV infection: Comparison of cohort studies with randomized controlled trials. AIDS 1999;13:2075-82.
    • (1999) AIDS , vol.13 , pp. 2075-2082
    • Phillips, A.N.1    Grabar, S.2    Tassie, J.M.3
  • 13
    • 0035486836 scopus 로고    scopus 로고
    • Impact of protease inhibitor containing combination antiretroviral therapies on height and weight growth in HIV infected children
    • Buchacz K, Cervia JS, Lindsey JC, et al. Impact of protease inhibitor containing combination antiretroviral therapies on height and weight growth in HIV infected children. Pediatrics 2001;108:e72.
    • (2001) Pediatrics , vol.108
    • Buchacz, K.1    Cervia, J.S.2    Lindsey, J.C.3
  • 14
    • 0031804532 scopus 로고    scopus 로고
    • A phase I/II study of the protease inhibitor indinavir in children with HIV infection
    • Mueller BU, Sleasman J, Nelson RP, Jr, et al. A phase I/II study of the protease inhibitor indinavir in children with HIV infection. Pediatrics 1998;102:101-9.
    • (1998) Pediatrics , vol.102 , pp. 101-109
    • Mueller, B.U.1    Sleasman, J.2    Nelson Jr, R.P.3
  • 15
    • 17044454954 scopus 로고    scopus 로고
    • Nucleoside analogs plus retinovir in stable antiretroviral therapy experienced HIV infected children: A randomized controlled trial
    • Nachman SA, Stanley K, Yogev R, et al. Nucleoside analogs plus retinovir in stable antiretroviral therapy experienced HIV infected children: A randomized controlled trial. JAMA, 2000;283:492-8.
    • (2000) JAMA , vol.283 , pp. 492-498
    • Nachman, S.A.1    Stanley, K.2    Yogev, R.3
  • 16
    • 0033043731 scopus 로고    scopus 로고
    • Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving Zidovudine monotherapy during pregnancy
    • Italian Register for HIV infection in children
    • Italian Register for HIV infection in children. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving Zidovudine monotherapy during pregnancy. AIDS 1999;13:927-33.
    • (1999) AIDS , vol.13 , pp. 927-933


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.